Escaping from COVID-19 emergency accounting on previously infected subjects?

Affiliations

¹ Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, Italy.
² High School Master O2-O3-AHT University of Pavia, Pavia, Italy.

Comment

Salvatore Chirumbolo et al. J Med Virol. 2022 Jun.

. 2022 Jun;94(6):2352-2353.

doi: 10.1002/jmv.27645. Epub 2022 Feb 8.

¹ Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, Italy.
² High School Master O2-O3-AHT University of Pavia, Pavia, Italy.

No abstract available

Conflict of interest statement

The authors declare no conflict of interest.

Will the COVID-19 pandemic end with the Delta and Omicron variants?
Wang C, Han J. Wang C, et al. Environ Chem Lett. 2022;20(4):2215-2225. doi: 10.1007/s10311-021-01369-7. Epub 2022 Jan 15. Environ Chem Lett. 2022. PMID: 35069059 Free PMC article. No abstract available.

1. Wang C, Han J. Will the COVID‐19 pandemic end with the Delta and Omicron variants? Environ Chem Lett. 2022. - PMC - PubMed
1. Karim SSA, Karim QA. Omicron SARS‐CoV‐2 variant: a new chapter in the COVID‐19 pandemic. Lancet. 2021;11398(10317):2126‐2128. - PMC - PubMed
1. Khan K, Karim F, Cele S, et al. Omicron infection enhances neutralizing immunity against the Delta variant. medRxiv. 2021. 10.1101/2021.12.27.21268439 - DOI
1. Azzi L, Dalla Gasperina D, Veronesi G, et al. Mucosal immune response in BNT162b2 COVID‐19 vaccine recipients. EBioMedicine. 2021;75:103788. - PMC - PubMed
1. Bates TA, McBride SK, Leier HC, et al. Vaccination before or after SARS‐CoV‐2 infection leads to robust humoral response and antibodies that effectively neutralize variants. Sci Immunol. 2022. 10.1126/sciimmunol.abn8014 - DOI - PMC - PubMed